Valuation Emcure Pharmaceuticals Limited

Stocks

End-of-day quote NSE India S.E. Other stock markets 2026-08-03			5-day change	1st Jan Change
1,969.70 ^INR	+0.49%		+4.72%	+44.35%

07-21	Emcure Pharmaceuticals Limited Announces Cessation of P.S. Jayakumar as Independent Director and from Board Committees, Effective July 21, 2026	CI
07-20	Emcure Pharmaceuticals Limited completed the acquisition of an additional unknown minority stake in Gennova Biopharmaceuticals Ltd. from Sanjay Singh.	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2025	2026	2027	2028
Market Cap ¹	203,202	373,435	-	-
Change	-	83.78%	-	-
Enterprise Value (EV) ¹	208,106	306,160	377,999	367,918
Change	-	47.12%	-0.57%	-2.67%
P/E	29.4x	32.7x	32.2x	26x
PBR	4.57x	6.93x	6.13x	5.01x
PEG	-	1x	2x	1.1x
Capitalization / Revenue	2.57x	3.29x	3.58x	3.18x
EV / Revenue	2.64x	3.33x	3.62x	3.13x
EV / EBITDA	14.2x	17.1x	18x	14.9x
EV / EBIT	19.2x	22.3x	22.7x	18.4x
EV / FCF	33x	52.5x	34.4x	31.4x
FCF Yield	3.03%	1.9%	2.91%	3.18%
Dividend per Share ²	3	3.6	3.797	4.646
Rate of return	0.28%	0.23%	0.19%	0.24%
EPS ²	36.43	48.77	60.84	75.52
Distribution rate	8.23%	7.38%	6.24%	6.15%
Net sales ¹	78,960	92,035	104,411	117,360
EBITDA ¹	14,689	17,890	21,052	24,681
EBIT ¹	10,847	13,740	16,654	20,049
Net income ¹	6,813	9,244	11,435	14,187
Net Debt ¹	4,904	3,670	4,564	-5,517
Reference price ²	1,072.40	1,960.10	1,960.10	1,960.10
Nbr of stocks (in thousands)	189,483	189,590	-	-
Announcement Date	5/22/25	5/5/26	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
EMCURE PHARMACEUTICALS LIMITED	37.37x	4.13x	21.23x	0.16%	3.89B
ELI LILLY AND COMPANY	35.03x	12.19x	25.61x	0.59%	1,024B
JOHNSON & JOHNSON	27.48x	6.29x	17.54x	2.1%	618B
ABBVIE INC.	32.57x	7.42x	15.36x	2.76%	443B
ROCHE HOLDING AG	19.7x	4.68x	11.59x	2.83%	349B
NOVARTIS AG	22.21x	5.74x	14.32x	2.8%	297B
ASTRAZENECA PLC	21.76x	4.48x	12.7x	1.96%	264B
NOVO NORDISK A/S	13.48x	5.05x	10.4x	3.71%	209B
AMGEN INC.	25.29x	6.61x	11.66x	2.62%	208B
GILEAD SCIENCES, INC.	-46.92x	5.63x	31.08x	2.53%	162B
Average	18.80x	6.22x	17.15x	2.2%	357.76B
Weighted average by Cap.	24.36x	7.70x	18.23x	2.01%